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Q How do oral NSAIDs compare 
to other oral analgesics right after 
an acute musculoskeletal injury?
 nonsteroidal anti-inflammatory 
 drugs (NSAIDs) are at least as ef-
fective as other oral analgesics (opioids, 
acetaminophen) in relieving pain in the 
first few days after an acute musculoskel-
etal injury. Evidence also indicates that us-
ing NSAIDs results in fewer adverse events 
than using narcotics (strength of recom-
mendation [SOR]: A, systematic review of 
randomized controlled trials [RCTs], as 
well as individual RCTs).
Evidence summary
A Cochrane review of 16 RCTs (2144 patients) 
compared pain relief and return to function 
with oral NSAIDs and other oral analgesics 
(acetaminophen, opioids, or opioids plus ac-
etaminophen) in patients who had suffered a 
soft tissue injury within the past 48 hours.1 No 
differences between NSAIDs and acetamino-
phen were seen in pain relief at fewer than 
24 hours on a 100-point visual analog scale 
(VAS) (4 trials; 359 patients; mean difference 
[MD]=1.56; 95% confidence interval [CI], 
-3.9 to 7.0). Nor were differences observed in 
return to function at 7 days (3 trials, 386 pa-
tients; risk ratio [RR]=0.99; 95% CI, 0.90-1.09). 
No differences in pain relief between 
NSAIDs and oral opioids were seen at 
fewer than 24 hours (2 trials, 757 patients; 
MD=-0.02; 95% CI, -3.71 to 3.68) nor at days 
4 to 6 (one trial, 706 patients; MD=-2.9; 
95% CI, -6.06 to 0.26). Compared with 
NSAIDs, opioids showed a small increase in 
return to function at 7 days (2 trials, 749 pa-
tients; RR=1.13; 95% CI, 1.03-1.25), but the 
combination of acetaminophen and opioids 
didn’t show a difference (one trial, 89 pa-
tients; RR= 1.28; 95% CI, 0.90-1.81). 
Adverse gastrointestinal events (not de-
fined) were no different between NSAIDs 
and acetaminophen (7 trials, 627 patients; 
RR=1.76; 95% CI, 0.99-3.14) and occurred 
less often with NSAIDs than with oral opioids 
(2 trials, 769 patients; RR=0.51; 95% CI, 0.37-
0.69). Overall, the authors concluded that 
low-quality evidence consistently showed 
NSAIDs were at least equal to other oral an-
algesics in efficacy of pain relief and return to 
function.
Naproxen vs oxycodone:  
The opioid has more adverse effects 
A double-blind, noninferiority, random-
ized trial (published after the Cochrane re-
view search date) compared the effects of 
treatment with a single dose of oxycodone 
with a single dose of naproxen in 150 adult 
emergency department (ED) patients in a 
tertiary care academic center who had acute 
soft tissue injury and pain scores between 
3 and 7 (on a 1-to-10 scale).2 Injuries included 
sprains, strains, contusions, low-back injury, 
and intervertebral disk problems. The au-
thors didn’t clearly define “acute” with regard 
to time from injury. 
Patients were randomized and given a 
single dose of oxycodone 10 mg or naproxen 
250 mg with water. Pain scores and adverse 
effects were reassessed at 30 minutes and 
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60 minutes after administration, and a 
follow-up phone call was placed at 24 hours 
to evaluate further need for analgesics and 
adverse effects. 
Baseline pain scores before medica-
tion administration were similar in the 
2 groups (6.21 for the oxycodone group, 6 for 
the naproxen group). No difference in pain 
scores between oxycodone and naproxen 
was seen at 30 minutes (4.5 vs 4.4; P=.76) or 
60 minutes (2.5 vs 2.6; P=.45). The number of 
patients who required more analgesics within 
24 hours after administration didn’t differ 
significantly between the oxycodone group 
and the naproxen group (12 patients vs 5 pa-
tients; P=.07). 
The study evaluated adverse effects, in-
cluding nausea, vomiting, dizziness, drowsi-
ness, pruritus, and epigastric pain. Overall, 
22% of patients (33) from both groups com-
bined experienced at least one adverse effect. 
The oxycodone group reported more adverse 
effects overall (36% vs 8%; RR=4.5; 95% CI, 
2.0-10.2;). Ten patients experienced nausea, 
6 vomiting, 4 dizziness, 3 drowsiness, and 
2 pruritis. In the naproxen group, 4 patients 
experienced nausea; no other adverse effects 
were reported.
Acetaminophen, indomethacin,  
and diclofenac are equivalent
A double-blind RCT in a university hospital 
ED in Hong Kong compared patients older 
than 16 years with “isolated painful limb in-
jury” after trauma who received combina-
tions of analgesics or placebo.3 Patients were 
recruited during typical work-week hours 
(Monday to Friday, 9 am to 5 pm) and ran-
domized into 4 groups: acetaminophen 1 g 
plus placebo (66 patients), placebo plus in-
domethacin 25 mg (71 patients), placebo plus 
diclofenac 25 mg (69 patients), or acetamino-
phen 1 g  plus diclofenac 25 mg (94 patients). 
Each patient was given the group’s des-
ignated combination of analgesics in the ED 
and asked to rate pain on a 0-to-100 visual 
analog pain scale (VAPS) at 0, 30, 60, 90, and 
120 minutes after administration. Patients 
then left the ED with a 3-day course of their 
analgesic combination and were instructed 
to take the medication 4 times daily on the 
first day and 3 times daily thereafter. Patients 
recorded pain scores on the VAPS 3 times 
daily after discharge and at follow-up 5 to 
8 days after initial presentation. Intention-
to-treat analysis was done for patients lost to 
follow-up. A change in VAPS of 13 was con-
sidered clinically significant. 
All groups started with similar pain 
scores (30 at rest and 70 with activity) and 
didn’t achieve clinically significant pain relief 
within the first hour (mean change in VAPS 
<13). At 90 minutes, all groups achieved a 
mean change in VAPS >13, with no statistic- 
ally significant difference between the groups. 
Adverse effects were rare (7% total), and none 
were severe (no gastrointestinal hemorrhage 
or renal damage). 
Outside the ED, the acetaminophen-
diclofenac combination group showed the 
greatest pain score reduction at every time 
point at rest and with activity, but none of 
the reductions were statistically or clinically 
significant (results presented graphically). 
No difference was found between the groups 
in number of patients who completed the 
course of analgesics, took additional analge-
sia, tried Chinese medicine, or returned to 
the ED within 30 days. 
Limitations to the study included that the 
medication dosages may be much lower than 
typical dosages given in the United States and 
therefore lack applicability. The study also 
didn’t include a true placebo arm.                 JFP
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